Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients

NCT00364468 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

107

Enrollment

INDUSTRY

Sponsor class

Conditions

Neutropenia

Interventions

DRUG: pegfilgrastim

Sponsor

Kyowa Kirin Co., Ltd.